sorbitol has been researched along with Albuminuria in 15 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the therapeutic effect of losartan on type 2 diabetes mellitus (DM2) with gas chromatography (GC)-based metabonomics." | 7.74 | [Assessment of therapeutic effect of losartan on diabetes mellitus with gas chromatography-based metabonomics]. ( Gao, P; Lu, X; Shi, XZ; Xu, GW; Yuan, KL, 2007) |
| "We investigated the role played by sorbitol accumulation in the kidney in the development of diabetic albuminuria." | 7.72 | Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency. ( Ii, S; Itakura, M; Kudo, E; Moritani, M; Ohta, M; Tachikawa, T; Yamaoka, T; Yoshimoto, K, 2004) |
| "Sorbinil treatment completely prevented renal cortical sorbital accumulation, but did not abolish kidney enlargement or the increase in ultrafiltration pressure and glomerular filtration rate." | 5.28 | Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats. ( Aperia, A; Celsi, G; Eklöf, AC; Körner, A; Linné, T; Persson, B, 1992) |
| "Sodium-glucose co-transporter type 2 inhibitors (luseogliflozin 5 mg/day or canagliflozin 100 mg/day) reduced body weight, HbA1c, albuminuria, estimated glomerular filtration rate and office blood pressure." | 3.85 | Sodium-glucose co-transporter type 2 inhibitors reduce evening home blood pressure in type 2 diabetes with nephropathy. ( Kishimoto, M; Ohta, M; Suzuki, H; Takenaka, T; Tomonaga, O, 2017) |
| " Serum-advanced glycation end-products level, malonaldehyde level, sorbitol concentration of red blood cell, 24 h albuminuria excretion were significantly decreased, whereas activity of serum superoxide dismutase and glutathione peroxidase and creatinine clearance rate were increased by mangiferin." | 3.76 | Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. ( Cui, X; Li, W; Li, X; Sun, X; Zhu, Q, 2010) |
| "To assess the therapeutic effect of losartan on type 2 diabetes mellitus (DM2) with gas chromatography (GC)-based metabonomics." | 3.74 | [Assessment of therapeutic effect of losartan on diabetes mellitus with gas chromatography-based metabonomics]. ( Gao, P; Lu, X; Shi, XZ; Xu, GW; Yuan, KL, 2007) |
| "We investigated the role played by sorbitol accumulation in the kidney in the development of diabetic albuminuria." | 3.72 | Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency. ( Ii, S; Itakura, M; Kudo, E; Moritani, M; Ohta, M; Tachikawa, T; Yamaoka, T; Yoshimoto, K, 2004) |
| "Epalrestat is an inhibitor of aldose reductase in the polyol pathway and is used for the management of diabetic neuropathy clinically." | 1.51 | The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation. ( Aa, JY; Ding, F; Gao, HX; He, J; Sun, RB; Wang, GJ; Wang, JK; Xie, Y; Yang, N; Zeng, CH; Zhang, JW; Zhu, XD, 2019) |
| "Sorbinil treatment completely prevented renal cortical sorbital accumulation, but did not abolish kidney enlargement or the increase in ultrafiltration pressure and glomerular filtration rate." | 1.28 | Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats. ( Aperia, A; Celsi, G; Eklöf, AC; Körner, A; Linné, T; Persson, B, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takenaka, T | 1 |
| Kishimoto, M | 1 |
| Ohta, M | 2 |
| Tomonaga, O | 1 |
| Suzuki, H | 1 |
| He, J | 1 |
| Gao, HX | 1 |
| Yang, N | 1 |
| Zhu, XD | 1 |
| Sun, RB | 1 |
| Xie, Y | 1 |
| Zeng, CH | 1 |
| Zhang, JW | 1 |
| Wang, JK | 1 |
| Ding, F | 1 |
| Aa, JY | 1 |
| Wang, GJ | 1 |
| Yuan, KL | 1 |
| Shi, XZ | 1 |
| Lu, X | 1 |
| Gao, P | 1 |
| Xu, GW | 1 |
| Li, X | 2 |
| Cui, X | 1 |
| Sun, X | 1 |
| Zhu, Q | 1 |
| Li, W | 1 |
| Ouchi, H | 1 |
| Isogai, S | 2 |
| Ii, S | 1 |
| Kudo, E | 1 |
| Yamaoka, T | 1 |
| Tachikawa, T | 1 |
| Moritani, M | 1 |
| Itakura, M | 1 |
| Yoshimoto, K | 1 |
| Fagius, J | 1 |
| Jameson, S | 1 |
| Soulis-Liparota, T | 1 |
| Cooper, ME | 1 |
| Dunlop, M | 1 |
| Jerums, G | 1 |
| Lever, M | 1 |
| Sizeland, PC | 1 |
| Bason, LM | 1 |
| Hayman, CM | 1 |
| Robson, RA | 1 |
| Chambers, ST | 1 |
| Inokuchi, T | 1 |
| Ohe, K | 1 |
| Yoshii, H | 1 |
| Uchino, H | 1 |
| Ohmura, C | 1 |
| Watanabe, K | 1 |
| Tanaka, Y | 1 |
| Kawamori, R | 1 |
| Brownlee, M | 1 |
| Körner, A | 1 |
| Celsi, G | 1 |
| Eklöf, AC | 1 |
| Linné, T | 1 |
| Persson, B | 1 |
| Aperia, A | 1 |
| Tilton, RG | 1 |
| Chang, K | 1 |
| Pugliese, G | 1 |
| Eades, DM | 1 |
| Province, MA | 1 |
| Sherman, WR | 1 |
| Kilo, C | 1 |
| Williamson, JR | 1 |
| Kowluru, A | 1 |
| Kowluru, R | 1 |
| Bitensky, MW | 1 |
| Corwin, EJ | 1 |
| Solomon, SS | 1 |
| Johnson, JD | 1 |
1 review available for sorbitol and Albuminuria
| Article | Year |
|---|---|
[Diabetic nephropathy--predictive methods].
Topics: Albuminuria; Animals; Biomarkers; Collagen Type IV; Diabetic Nephropathies; Fibronectins; Fructose; | 2002 |
2 trials available for sorbitol and Albuminuria
| Article | Year |
|---|---|
Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
Topics: Adult; Albuminuria; Aldehyde Reductase; Autonomic Nervous System; Clinical Trials as Topic; Diabetic | 1981 |
Abnormal glycine betaine content of the blood and urine of diabetic and renal patients.
Topics: Adult; Albuminuria; Betaine; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus; Fe | 1994 |
12 other studies available for sorbitol and Albuminuria
| Article | Year |
|---|---|
Sodium-glucose co-transporter type 2 inhibitors reduce evening home blood pressure in type 2 diabetes with nephropathy.
Topics: Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Canag | 2017 |
The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.
Topics: Albuminuria; Aldehyde Reductase; Animals; Diabetic Nephropathies; Enzyme Inhibitors; Fructose; Inosi | 2019 |
[Assessment of therapeutic effect of losartan on diabetes mellitus with gas chromatography-based metabonomics].
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Biomarkers; Chromatography, Gas; Creatinine; Deoxyguanosin | 2007 |
Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
Topics: Albuminuria; Animals; Blood Glucose; Cell Proliferation; Cells, Cultured; Collagen Type IV; Creatini | 2010 |
Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency.
Topics: Albuminuria; Aldehyde Reductase; Animals; Diabetic Nephropathies; Humans; L-Iditol 2-Dehydrogenase; | 2004 |
The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.
Topics: Albuminuria; Aldehyde Reductase; Animals; Antioxidants; Blood Glucose; Body Weight; Butylated Hydrox | 1995 |
Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Albuminuria; Aldehyde Reductase; Animals; Anions; Basement Membrane; Blood Glu | 1995 |
Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity.
Topics: Adult; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retino | 2001 |
Glycosylation of proteins and microangiopathy.
Topics: Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diglycerides; Dogs; Gl | 1992 |
Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.
Topics: Albuminuria; Aldehyde Reductase; Analysis of Variance; Animals; Diabetes Mellitus, Experimental; Glo | 1992 |
Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
Topics: Albuminuria; Aldehyde Reductase; Animals; Cardiac Output; Diabetes Mellitus, Experimental; Fluorenes | 1989 |
Suggested mechanism for the selective excretion of glucosylated albumin. The effects of diabetes mellitus and aging on this process and the origins of diabetic microalbuminuria.
Topics: Adolescent; Adult; Aging; Albuminuria; Animals; Cations; Child; Diabetes Mellitus, Experimental; Dia | 1987 |